Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

Nippon India ETF BSE Sensex Next 50 · Direct ✕Nippon India Nifty Pharma ETF · Direct ✕

Growth of ₹10,000

Basics

Nippon India ETF BSE Sensex Next 50Nippon India Nifty Pharma ETF
CategoryEquity ETFsEquity ETFs
PlanDirectDirect
Fund houseNippon IndiaNippon India
NAV₹93.7420₹29.1863
NAV date20 Nov 202620 Nov 2026
History7.3 years5.4 years
Expense ratio0.3%0.2%
StarsNot ratedNot rated
Growth Score——

Returns

Nippon India ETF BSE Sensex Next 50Nippon India Nifty Pharma ETF
1 month+7.69%+10.82%
3 months−0.74%+7.43%
6 months+6.50%+14.54%
YTD+2.53%+25.40%
1 year+2.36%+25.57%
3 years (CAGR)+15.60%+22.02%
5 years (CAGR)+13.15%+16.60%
10 years (CAGR)——
Since launch+17.05%+14.02%

Risk

Nippon India ETF BSE Sensex Next 50Nippon India Nifty Pharma ETF
Volatility18.5%15.0%
Downside volatility12.2%9.0%
Sharpe0.491.04
Sortino0.751.72
Calmar0.751.33
Return / risk0.841.47
Deepest fall−38.30%−20.98%
Days to recover239136
Below its high−1.19%−1.75%

Against benchmark

Nippon India ETF BSE Sensex Next 50Nippon India Nifty Pharma ETF
Alpha—+0.00%
Beta—1.00
R²—100.0%
Up capture—100.0%
Down capture—100.0%
Tracking error—0.0%
Information ratio——
Treynor—0.14

Consistency

Nippon India ETF BSE Sensex Next 50Nippon India Nifty Pharma ETF
Best 1-year+99.69%+65.21%
Middle 1-year+12.83%+13.46%
Worst 1-year−9.67%−15.30%
1-year periods with a loss12.2%25.8%
Middle 3-year+21.20%+20.51%
Positive months69.4%61.1%
Best day+4.88%+3.64%
Worst day−6.38%−4.03%
Worst 5% day−1.81%−1.62%
Positive days56.8%54.4%
NAVs a year248248

SIP of ₹10,000 a month

Nippon India ETF BSE Sensex Next 50Nippon India Nifty Pharma ETF
5-year XIRR+13.91%+20.60%
5-year value₹8,56,344₹10,11,738
3-year XIRR+8.22%+19.58%
1-year XIRR+8.32%+34.31%

Holdings overlap i

Nippon India ETF BSE Sensex Next 50Nippon India Nifty Pharma ETF
Nippon India ETF BSE Sensex Next 50—7%
Nippon India Nifty Pharma ETF7%—

Share of money in the same stocks, by weight. Above 50% means much of one fund repeats the other.

Held by all of them

StockNippon India ETF BSE Sensex Next 50Nippon India Nifty Pharma ETF
Divi's Laboratories Limited4.70%12.28%
Lupin Limited1.85%4.83%

Sectors and company size

Nippon India ETF BSE Sensex Next 50Nippon India Nifty Pharma ETF
Large companies57.8%45.3%
Mid companies42.2%47.1%
Small companies—7.6%
Top 10 holdings30.8%78.6%
Largest sectorBanks 15%Pharmaceuticals & Biotechnology 100%

Search Growth